drugset / Trial / NCT00537719

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

NCT00537719

Phase 1 Completed 34 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will use scintigraphy techniques to measure gastric emptying rate of liquid and solid food at baseline and after administration of GSK716155 or placebo.

Timeline

Start
2007-12-07
Primary completion
2008-04-04
Completion
2008-04-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator albiglutide Peptide Subcutaneous